<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34508486</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1815-672X</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>240</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>JNMA; journal of the Nepal Medical Association</Title><ISOAbbreviation>JNMA J Nepal Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Long COVID Patient Symptoms and its Evaluation and Management.</ArticleTitle><Pagination><StartPage>823</StartPage><EndPage>831</EndPage><MedlinePgn>823-831</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31729/jnma.6355</ELocationID><Abstract><AbstractText>While the acute case burdens and deaths from the COVID-19 pandemic (in Nepal approaching 700,000 and 10,000 respectively) have been costly, the characteristics and potentially huge dimensions of the chronic disease sequelae of this infectious disease are only slowly becoming apparent. We reviewed Pub Med, major medical meeting and medical journal, and investigative journalist materials seeking to frame and describe COVID-19 chronic disease. The consequences of COVID-19 infections follow major organ damage, and induction of immunological and hormonal systems dysfunction. The first injuries are consequent to direct viral effects on tissues, and vasculitis, endothelialitis, thrombosis and inflammatory events. Pulmonary, cardiac, brain, and kidney tissues incur function-limiting damage, with dyspnea, arrythmias, decreased exercise capacity, cognitive dysfunction, and decreased glomerular filtration rates. The second process is characterized by immune dysregulation and autoimmunity, and dysfunction of hormonal regulation systems, with high, fluctuating levels of physical and mental fatigue, multiple-site pain and ache, and non-restorative sleep, in 10-30% of cases. This communication proposes evaluation and management of chronic COVID-19 patients with efficient assessment of commonest symptoms, targeted physical examination and organ function testing, and interventions based on specific organ functional status, and experience with similar chronic immune syndromes, such as myalgic encephalomyelitis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sundar Shrestha</LastName><ForeName>Deepak</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, People's Dental College and Hospital, Kathmandu, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Love</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Marquette University, Milwaukee, Wisconsin, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Nepal</Country><MedlineTA>JNMA J Nepal Med Assoc</MedlineTA><NlmUniqueID>0045233</NlmUniqueID><ISSNLinking>0028-2715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>
<b>None.</b>
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34508486</ArticleId><ArticleId IdType="pmc">PMC9107834</ArticleId><ArticleId IdType="doi">10.31729/jnma.6355</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patient-Led Research Collaborative.  Report: What Does COVID-19 Recovery Actually Look Like? [Internet] 2021. 2020. May 2,  [
Mar 27;
2021 ]. https://patientresearchcovid19.com/research/report-1/ Available from:</Citation></Reference><Reference><Citation>Yong E.  Long-Haulers Are Redefining COVID-19. The Atlantic [Internet].; 2020. 2020. Aug 19,  [
Mar 27;
2021 ]. https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/?utm_source=share&amp;utm_campaign=share Available from:</Citation></Reference><Reference><Citation>Velasquez-Manoff M.  What If You Never Get Better From Covid-19? [Internet] New York (USA): The New York Times; 2021. Jan 24,  [
Mar 27;
2021 ]. https://www.nytimes.com/2021/01/21/magazine/covid-aftereffects.html?smid=url-share Available from:</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;32. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271&#x2013;80e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkesh A, DaeiSorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, et al. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg. 2020;103(5):1783&#x2013;96. doi: 10.4269/ajtmh.20-0986.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0986</ArticleId><ArticleId IdType="pmc">PMC7646754</ArticleId><ArticleId IdType="pubmed">32940201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. Jama. 2020;324(8):799&#x2013;801. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089&#x2013;98. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473&#x2013;4. doi: 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255&#x2013;73. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. Potential association of mast cells with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(3):217&#x2013;8. doi: 10.1016/j.anai.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7644430</ArticleId><ArticleId IdType="pubmed">33161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;20. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372&#x2013;4. doi: 10.1056/NEJMc2010419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Udwadia ZF, Tripathi AR, Nanda VJ, Joshi SR. Prognostic Factors for Adverse Outcomes in COVID-19 Infection. J Assoc Physicians India. 2020;68(7):62&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32602683</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A, Kostov B, Mas-Heredia M, Vilanova-Rotllan S, Sequeira-Aymar E, Sans-Corrales M, et al. Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona. PLoS One. 2020;15(8):e0237960-e. doi: 10.1371/journal.pone.0237960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237960</ArticleId><ArticleId IdType="pmc">PMC7444503</ArticleId><ArticleId IdType="pubmed">32822413</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi RT, Lynch JB. Del Rio C. Mild or Moderate Covid-19. N Engl J Med. 2020;383(18):1757&#x2013;66. doi: 10.1056/NEJMcp2009249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451&#x2013;60. doi: 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F. Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y. Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020:ciaa1750. doi: 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Belluck P.  Covid Survivors With Long-Term Symptoms Need Urgent Attention, Experts Say [Internet]. New York (USA): The New York Times; 2020. Dec 4,  [
Mar 27;
2021 ]. https://www.nytimes.com/2020/12/04/health/covid-long-term-symptoms.html Available from:</Citation></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15a;cieszka J, D&#x105;ek J, Cie&#x15b;lik P. Post-Lyme disease syndrome. Reumatologia. 2015;53(1):46&#x2013;8. doi: 10.5114/reum.2015.50557.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2015.50557</ArticleId><ArticleId IdType="pmc">PMC4847307</ArticleId><ArticleId IdType="pubmed">27407225</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med. 2000;109(7):531&#x2013;7. doi: 10.1016/S0002-9343(00)00560-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(00)00560-X</ArticleId><ArticleId IdType="pubmed">11063953</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. 1998;173:475&#x2013;81. doi: 10.1192/bjp.173.6.475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.173.6.475</ArticleId><ArticleId IdType="pubmed">9926075</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Thomas JM, Kangro HO, Bruce-Jones WD, Amess J, Crawford DH, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358(9297):1946&#x2013;54. doi: 10.1016/S0140-6736(01)06961-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)06961-6</ArticleId><ArticleId IdType="pubmed">11747919</ArticleId></ArticleIdList></Reference><Reference><Citation>Berelowitz GJ, Burgess AP, Thanabalasingham T, Murray-Lyon IM, Wright DJ. Post-hepatitis syndrome revisited. J Viral Hepat. 1995;2(3):133&#x2013;8. doi: 10.1111/j.1365-2893.1995.tb00018.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.1995.tb00018.x</ArticleId><ArticleId IdType="pubmed">7493307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayres JG, Flint N, Smith EG, Tunnicliffe WS, Fletcher TJ, Hammond K, et al. Post-infection fatigue syndrome following Q fever. Qjm. 1998;91(2):105&#x2013;23. doi: 10.1093/qjmed/91.2.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/91.2.105</ArticleId><ArticleId IdType="pubmed">9578893</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;7. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543&#x2013;50. doi: 10.1111/j.1440-1843.2010.01720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020;52(5):jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): National Academies Press (US); 2015. Feb 10,</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibble JJ. Mc Grath SJ, Ponting CP. Genetic risk factors of ME/CFS: a critical review. Hum Mol Genet. 2020;29(R1):R117&#x2013;r24. doi: 10.1093/hmg/ddaa169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa169</ArticleId><ArticleId IdType="pmc">PMC7530519</ArticleId><ArticleId IdType="pubmed">32744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock TJ, Fritsch P, Rice MA, Jr, del Rosario RM, Miller DB, Fletcher MA, et al. A role for homeostatic drive in the perpetuation of complex chronic illness: Gulf War Illness and chronic fatigue syndrome. PLoS One. 2014;9(1):e84839. doi: 10.1371/journal.pone.0084839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0084839</ArticleId><ArticleId IdType="pmc">PMC3885655</ArticleId><ArticleId IdType="pubmed">24416298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, Peterson DL, Gottschalk CG, Schultz AF, Che X, Eddy ML, Komaroff AL, Lipkin WI. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015:e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014;16:7&#x2013;17. doi: 10.1016/j.mito.2013.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2013.08.006</ArticleId><ArticleId IdType="pubmed">23981537</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner P, Harrer T, Scheibenbogen C, Lamer S, Schlosser A, Naviaux RK, et al. Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Immunohorizons. 2020;4(4):201&#x2013;15. doi: 10.4049/immunohorizons.2000006.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2000006</ArticleId><ArticleId IdType="pubmed">32327453</ArticleId></ArticleIdList></Reference><Reference><Citation>Saud B, Paudel G. The Threat of Ambient Air Pollution in Kathmandu, Nepal. Journal of Environmental and Public Health. 2018;2018:1504591. doi: 10.1155/2018/1504591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1504591</ArticleId><ArticleId IdType="pmc">PMC6077323</ArticleId><ArticleId IdType="pubmed">30112009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak L, Gayan S, Pal B, Talukdar J, Bhuyan S, Sandhya S, et al. Coronavirus activates a stem cell-mediated defense mechanism that accelerates the activation of dormant tuberculosis: implications for the COVID-19 pandemic 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.06.077883</ArticleId><ArticleId IdType="pmc">PMC8054533</ArticleId><ArticleId IdType="pubmed">33887214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokharel P.  Could an anti-TB vaccine be protecting Nepalis? [Internet]. Kathmandu (Nepal): Nepali Times; 2020. Apr 6,  [
Mar 27;
2021 ]. https://www.nepalitimes.com/latest/could-an-anti-tb-vaccine-be-protecting-nepalis/ Available from:</Citation></Reference><Reference><Citation>Mahler DA.  [
Mar 27;
2021 ];mMRC (Modified Medical Research Council) Dyspnea Scale [Internet]  https://www.mdcalc.com/mmrc-modified-medical-research-council-dyspnea-scale Available from:</Citation></Reference><Reference><Citation>ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111&#x2013;7. doi: 10.1164/ajrccm.166.1.at1102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.166.1.at1102</ArticleId><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mini-Mental State Exam (MMSE) Alzheimer's/Dementia Test: Administration, Accuracy and Scoring [Internet].   [
Mar 27;
2021 ]. https://www.dementiacarecentral.com/mini-mental-state-exam/ Available from:</Citation></Reference><Reference><Citation>CDE Detailed Report [Internet].   USA: NINDS Common Data Elements;  [
Mar 27;
2021 ]. https://commondataelements.ninds.nih.gov/cde_detailed_report/25231/Activities%20of%20Daily%20Living%252FPerformance/Outcomes%20and%20End%20Points/Myalgic%20Encephalomy-elitis%252FChronic%20Fatigue%20Syndrome/Physical%20Functioning%20and%20Activities%20of%20Daily%20Living Available from:</Citation></Reference><Reference><Citation>Wang G, Wu C, Zhang Q, Wu F, Yu B, Lv J, et al. C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation. Open Forum Infectious Diseases. 2020;7(5) doi: 10.1093/ofid/ofaa153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa153</ArticleId><ArticleId IdType="pmc">PMC7197542</ArticleId><ArticleId IdType="pubmed">32455147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rklund G, Dadar M, Pen JJ, Chirumbolo S, Aaseth J. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed Pharmacother. 2019;109:1000&#x2013;7. doi: 10.1016/j.biopha.2018.10.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.10.076</ArticleId><ArticleId IdType="pubmed">30551349</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz RI, Freeman PR. Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials. Med Hypotheses. 2020 Oct;143:109851. doi: 10.1016/j.mehy.2020.109851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109851</ArticleId><ArticleId IdType="pmc">PMC7242962</ArticleId><ArticleId IdType="pubmed">32534175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton MJ, Chapman BP. Van Marwijk H. Low-dose naltrexone as a treatment for chronic fatigue syndrome. BMJ Case Reports. 2020;13(1):e232502. doi: 10.1136/bcr-2019-232502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-232502</ArticleId><ArticleId IdType="pmc">PMC6954765</ArticleId><ArticleId IdType="pubmed">31911410</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndromeassociated brain fog and chemofog: Luteolin to the rescue. BioFactors. 2021;47(2):232&#x2013;41. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, et al. Minocycline attenuates lipopoly saccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation. 2008;5:15. doi: 10.1186/1742-2094-5-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-5-15</ArticleId><ArticleId IdType="pmc">PMC2412862</ArticleId><ArticleId IdType="pubmed">18477398</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, et al. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. Curr Drug Targets. 2011;12(11):1595&#x2013;653. doi: 10.2174/138945011798109464.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945011798109464</ArticleId><ArticleId IdType="pmc">PMC3170500</ArticleId><ArticleId IdType="pubmed">21561421</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatoo MI, Gopalakrishnan A, Saxena A, Parray OR, Tufani NA, Chakraborty S, et al. Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review. Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):39&#x2013;58. doi: 10.2174/1872213X12666180115153635.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1872213X12666180115153635</ArticleId><ArticleId IdType="pubmed">29336271</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients. MDPI AG. 2021 Mar 31;13(4):1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejos J, Zoni R, Bangher M, Villamandos S, Bobadilla A. Plano F et al. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infectious Diseases. 2021;21(1) doi: 10.1186/s12879-021-06348-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06348-5</ArticleId><ArticleId IdType="pmc">PMC8250562</ArticleId><ArticleId IdType="pubmed">34215210</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton R.  The Covid-19 Catastrophe: What's Gone Wrong and How to Stop it Happening Again [Internet]. Cambridge,(UK): Polity Press; 2020.  [
Mar 27;
2021 ]. https://academic.oup.com/eurpub/article/31/1/234/5998562 Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckaa216</ArticleId></ArticleIdList></Reference><Reference><Citation>Mervosh S. They lived, but have yet to become well again [Internet]. New York (USA): The New York Times; 2020. Sep 29, [ Mar 27; 2021 ]. p. 8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>